Akero Therapeutics to Speak at 2024 Jefferies Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 29, 2024 – Akero Therapeutics, Inc. (Nasdaq: AKRO), a company dedicated to developing groundbreaking treatments for serious metabolic diseases, has announced its management team will present at the Jefferies Global Healthcare Conference. The presentation is scheduled for Wednesday, June 5, 2024, at 4:00 p.m. E.T. in New York, NY.

The conference presentation will be accessible via a live webcast through the investor relations section of Akero’s website. For those unable to attend the live session, an archived replay will be available on the site following the event.

About Akero Therapeutics

Akero Therapeutics is in the clinical stage of developing innovative treatments for severe metabolic conditions. The company focuses on diseases with significant unmet medical needs, such as metabolic-associated steatohepatitis (MASH). The lead product candidate, EFX, is under evaluation in several key clinical trials.

The SYMMETRY study, a 96-week Phase 2b trial, is investigating EFX in patients with compensated cirrhosis due to MASH (F4 fibrosis). In addition, Akero is conducting two Phase 3 clinical trials: the SYNCHRONY Histology study for patients with pre-cirrhotic MASH (F2-F3 fibrosis), and the SYNCHRONY Real-World study, which includes patients with MASH (F1-F3 fibrosis) or metabolic-associated steatosis with liver disease (MASLD). A third clinical trial, the SYNCHRONY Outcomes study for patients with compensated cirrhosis due to MASH (F4 fibrosis), is anticipated to commence in the second quarter of 2024.

These Phase 3 SYNCHRONY trials build upon the outcomes of two Phase 2b trials: the HARMONY study targeting pre-cirrhotic MASH (F2-F3 fibrosis) and the SYMMETRY study for compensated cirrhosis due to MASH (F4 fibrosis). Akero Therapeutics is headquartered in South San Francisco.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!